Abortion, Second Trimester
13
2
2
10
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
31%
4 trials in Phase 3/4
40%
4 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (13)
Foley Balloon for Cervical Preparation Before Dilation and Evacuation
Simultaneous Mifepristone and Misoprostol Versus Misoprostol Alone for Induction of Labor of Nonviable Second Trimester Pregnancy: a Pilot Randomized Controlled Trial
Cervical Preparation for Same-Day Dilation & Evacuation
Transcervical Balloon Compared to Osmotic Dilators Prior to Surgical Abortion
Induction of Abortion in the Second Trimester
Second-trimester TOP : a Retrospective Study Comparing Complications at 12-14 vs 14-16 Weeks of Gestation
Clotting Parameters After Medical Abortion
Overnight Pain Treatment Investigating Opioids vs. Nonopioids
24-hour Mifepristone and Buccal Versus Mifepristone and Vaginal Misoprostol for Cervical Preparation for D&E
Uterocervical Angle in the Termination of Second Trimester Pregnancy
Misoprostol With And Without Transcervical Balloon Catheter In Second Trimester Termination Of Pregnancy
Mifepristone and Mid-Trimester Termination of Pregnancy
A Pilot Study of Priming Before Induction Termination of Pregnancy